Catalyst Pharmaceuticals (CPRX) Raw Materials (2023 - 2026)

Catalyst Pharmaceuticals (CPRX) has 4 years of Raw Materials data on file, last reported at $16.9 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials rose 127.02% year-over-year to $16.9 million; the trailing twelve-month figure through Mar 2026 stood at $16.9 million (up 127.02% YoY), and the FY2025 full-year result was $17.1 million, up 162.92% from the prior year.
• Raw Materials for Q1 2026 stood at $16.9 million, down from $17.1 million in the prior quarter.
• Across five years, Raw Materials topped out at $17.1 million in Q4 2025 and bottomed at $1.9 million in Q4 2023.
• The 4-year median for Raw Materials is $6.9 million (2024), against an average of $8.9 million.
• The widest annual swing landed in 2024, when Raw Materials surged 241.26%; it then declined 7.34% in 2025.
• A 4-year view of Raw Materials shows it stood at $1.9 million in 2023, then soared by 241.26% to $6.5 million in 2024, then surged by 162.92% to $17.1 million in 2025, then fell by 1.51% to $16.9 million in 2026.
• The last three Raw Materials figures came in at $16.9 million (Q1 2026), $17.1 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.

Peer Comparison